Skip to main content
. 2022 Jan 15;33:105177. doi: 10.1016/j.rinp.2022.105177

Table 7.

Incremental cost-effectiveness ratio for scenario B.

Strategy Infection averted Cost IAR ACER ICER
Strategy 8: u2(t),u3(t) 1.9253×106 2.8104×103 1.4524 0.0015 0.0015
Strategy 6: u1(t),u3(t) 2.1128×106 1.3487×103 1.5239 6.3834×104 −0.0078
Strategy 7: u1(t),u4(t) 2.1751×106 1.7708×103 1.4506 8.1410×104 0.0068
Strategy 5: u1(t),u2(t) 2.2265×106 1.6871×103 1.5759 7.5775×104 −0.0016